Table 3 Patient characteristics of women with fetal growth restriction and control samples for gene (mRNA) expression studies.
Preterm controls (n = 10) | Fetal growth restriction (n = 14) | |
|---|---|---|
Maternal age, years Median (IQR) | 34 (26.5–37.5) | 30 (25.3–33.5) |
Gestational age at delivery, weeks Median (IQR) | 30 (29.4–31.6) | 32.7 (30.9–34.0)* |
Body mass index (kg/m2) Median (IQR) | 28.4 (24.0–30.0) | 25.8 (18.75–29.5) |
Parity no. (%) | ||
0 | 2 (20.0) | 9 (64.3) |
1 | 4 (40.0) | 2 (14.3) |
≥ 2 | 4 (40.0) | 3 (21.4) |
Highest SBP prior to delivery (mmHg) Median (IQR) | 120 (110–126.3) | 120 (115–126.3) |
Highest DBP prior to delivery (mmHg) Median (IQR) | 70 (67.5–76.25) | 76.5 (70–83.5)* |
Mode of delivery | ||
Vaginal (%) | 0 (0) | 0 (0) |
Caesarean Section (%) | 10 (100) | 14 (100) |
Birth weight (g) Median (IQR) | 1496 (1322–2011) | 1182 (973–1658) |